Category Specific RSS

Opinion

How to survive the rising rates environment

Interest rates have risen in Australia for the first time since 2010, which has been a long time coming, if anything we are late to the party.

Rate announcements and central bank meetings are usually followed by a week of increased volatility – we have certainly seen that so far.

With stocks and bonds on such unstable ground as of late, many investors have been fearing that central banks, in their attempts to dampen inflation, may inadvertently tip the economy into recession. 

We expect continued sharp corrections in the stock market where money will begin flowing and transitioning back more proportionately towards value stocks than we have seen over the last few years.

Expect investors to head especially towards staples like the big miners and defensive stocks that have fared relatively well in the current economic environment. 

The state of the current market raises a lot of questions in the near term. The best way to keep an eye on what’s next is to watch the bond market for future rate expectations, and listen closely to any updates from the Federal Open Market Committee (FOMC) and the RBA.

We talk about all of this and more in our latest podcast which is available below.

 

<center?

Emerald Financial

Emerald Financial is a financial services firm founded in 2005. We offer a diversified range of services, including; stock research and data, education courses, portfolio services, and financial news. Over the years, we have educated thousands of Australians to trade equities and derivative markets.

Recent Posts

AML3D announces stronger FY26, with positive EBITDA reported in the second half

Adelaide-based metal printing group books record $12.5 million revenue and a record $78 million sales…

3 days ago

Refurbished tech gives Harris Technology a second life

Harris Technology has found a higher-margin growth engine in an unlikely place: the market for…

5 days ago

Imagion Biosystems Advances MagSense® Phase 2 Trial

Imagion Biosystems (ASX: IBX) is moving its MagSense® HER2 Imaging Agent Phase 1b/2 clinical trial…

1 week ago

Acrux-developed Menopause Hormone Therapy to enter Australian market

Acrux (ASX:ACR) is set to bring its transdermal Estradiol spray Lenzetto® to the Australian market…

3 months ago

Evion Expands Critical Minerals Push with Nevada Fluorspar Option

The race to secure Western-aligned critical minerals supply chains is accelerating as governments and industry…

4 months ago

Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone

Green360 Technologies (ASX:GT3) has taken a major step forward in the commercialisation of its low-carbon…

4 months ago